Vaccines Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Vaccines Market size was valued at US$ 90.13 Billion in 2025 and is projected to reach US$ 230.79 Billion by 2033, growing at a CAGR of 12.47% during 2026–2033. Expanding immunization programs, rising adult vaccination uptake, technological advances in mRNA platforms, increasing infectious disease surveillance, and government-supported procurement initiatives are creating substantial long-term opportunities across developed and emerging healthcare systems.

Report Coverage

Type: Live Attenuated, Inactivated, Recombinant, mRNA Vaccine, Viral Vectors Vaccines, Toxoid
Route of Administration: Parenteral, Oral
Disease Indication: Viral Diseases, Bacterial Diseases
Age Group: Pediatric, Adults
Distribution Channel: Hospital, Retail Pharmacies, Government Suppliers

US$ 90.13 Bn Market size in 2025

US$ 230.79 Bn Market Size by 2033

12.47% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format PDF + Excel + PPT

No. of Pages: 350

Category Life Sciences

Report Code: BMIPUB00038845

Last Updated: 2026-09-21

Author

Krishna Sunthwal

Analyst Connect

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Vaccines Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Vaccines Market Global Analysis

6.2 Vaccines Market Revenue 2022-2033 (US$ Billion)

6.3 Vaccines Market Forecast Analysis

7. Vaccines Market Analysis – by Type

7.1 Live Attenuated

7.1.1 Overview
7.1.2 Live Attenuated: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.2 Inactivated

7.2.1 Overview
7.2.2 Inactivated: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.3 Recombinant

7.3.1 Overview
7.3.2 Recombinant: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.4 mRNA Vaccine

7.4.1 Overview
7.4.2 mRNA Vaccine: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.5 Viral Vectors Vaccines

7.5.1 Overview
7.5.2 Viral Vectors Vaccines: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.6 Toxoid

7.6.1 Overview
7.6.2 Toxoid: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Vaccines Market Analysis – by Route of Administration

8.1 Parenteral

8.1.1 Overview
8.1.2 Parenteral: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.2 Oral

8.2.1 Overview
8.2.2 Oral: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Vaccines Market Analysis – by Disease Indication

9.1 Viral Diseases

9.1.1 Overview
9.1.2 Viral Diseases: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.2 Bacterial Diseases

9.2.1 Overview
9.2.2 Bacterial Diseases : Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Vaccines Market Analysis – by Age Group

10.1 Pediatric

10.1.1 Overview
10.1.2 Pediatric: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.2 Adults

10.2.1 Overview
10.2.2 Adults: Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

11. Vaccines Market – Geographic Analysis

11.1 Overview

11.2 North America

11.2.1 Vaccines Market Breakdown, by Key Country, 2026 and 2033 (%)
11.2.1.1 Vaccines Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.1.1 US: Vaccines Market Breakdown, by Type
11.2.1.1.2 US: Vaccines Market Breakdown, by Route of Administration
11.2.1.1.3 US: Vaccines Market Breakdown, by Disease Indication
11.2.1.1.4 US: Vaccines Market Breakdown, by Age Group

11.2.1.2 Canada: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.2.1 Canada: Vaccines Market Breakdown, by Type
11.2.1.2.2 Canada: Vaccines Market Breakdown, by Route of Administration
11.2.1.2.3 Canada: Vaccines Market Breakdown, by Disease Indication
11.2.1.2.4 Canada: Vaccines Market Breakdown, by Age Group

11.2.1.3 Mexico: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.3.1 Mexico: Vaccines Market Breakdown, by Type
11.2.1.3.2 Mexico: Vaccines Market Breakdown, by Route of Administration
11.2.1.3.3 Mexico: Vaccines Market Breakdown, by Disease Indication
11.2.1.3.4 Mexico: Vaccines Market Breakdown, by Age Group

11.3 Europe

11.3.1 Vaccines Market Breakdown, by Key Country, 2026 and 2033 (%)
11.3.1.1 Vaccines Market – Revenue and Forecast Analysis – by Country
11.3.1.1 Germany: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.1.1 Germany: Vaccines Market Breakdown, by Type
11.3.1.1.2 Germany: Vaccines Market Breakdown, by Route of Administration
11.3.1.1.3 Germany: Vaccines Market Breakdown, by Disease Indication
11.3.1.1.4 Germany: Vaccines Market Breakdown, by Age Group

11.3.1.2 Italy: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.2.1 Italy: Vaccines Market Breakdown, by Type
11.3.1.2.2 Italy: Vaccines Market Breakdown, by Route of Administration
11.3.1.2.3 Italy: Vaccines Market Breakdown, by Disease Indication
11.3.1.2.4 Italy: Vaccines Market Breakdown, by Age Group

11.3.1.3 France: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.3.1 France: Vaccines Market Breakdown, by Type
11.3.1.3.2 France: Vaccines Market Breakdown, by Route of Administration
11.3.1.3.3 France: Vaccines Market Breakdown, by Disease Indication
11.3.1.3.4 France: Vaccines Market Breakdown, by Age Group

11.3.1.4 U.K.: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.4.1 U.K.: Vaccines Market Breakdown, by Type
11.3.1.4.2 U.K.: Vaccines Market Breakdown, by Route of Administration
11.3.1.4.3 U.K.: Vaccines Market Breakdown, by Disease Indication
11.3.1.4.4 U.K.: Vaccines Market Breakdown, by Age Group

11.3.1.5 Spain: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.5.1 Spain: Vaccines Market Breakdown, by Type
11.3.1.5.2 Spain: Vaccines Market Breakdown, by Route of Administration
11.3.1.5.3 Spain: Vaccines Market Breakdown, by Disease Indication
11.3.1.5.4 Spain: Vaccines Market Breakdown, by Age Group

11.3.1.6 Belgium: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.6.1 Belgium: Vaccines Market Breakdown, by Type
11.3.1.6.2 Belgium: Vaccines Market Breakdown, by Route of Administration
11.3.1.6.3 Belgium: Vaccines Market Breakdown, by Disease Indication
11.3.1.6.4 Belgium: Vaccines Market Breakdown, by Age Group

11.3.1.7 Netherlands: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.7.1 Netherlands: Vaccines Market Breakdown, by Type
11.3.1.7.2 Netherlands: Vaccines Market Breakdown, by Route of Administration
11.3.1.7.3 Netherlands: Vaccines Market Breakdown, by Disease Indication
11.3.1.7.4 Netherlands: Vaccines Market Breakdown, by Age Group

11.3.1.8 Luxembourg: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.8.1 Luxembourg: Vaccines Market Breakdown, by Type
11.3.1.8.2 Luxembourg: Vaccines Market Breakdown, by Route of Administration
11.3.1.8.3 Luxembourg: Vaccines Market Breakdown, by Disease Indication
11.3.1.8.4 Luxembourg: Vaccines Market Breakdown, by Age Group

11.3.1.9 Norway: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.9.1 Norway: Vaccines Market Breakdown, by Type
11.3.1.9.2 Norway: Vaccines Market Breakdown, by Route of Administration
11.3.1.9.3 Norway: Vaccines Market Breakdown, by Disease Indication
11.3.1.9.4 Norway: Vaccines Market Breakdown, by Age Group

11.3.1.10 Finland: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.10.1 Finland: Vaccines Market Breakdown, by Type
11.3.1.10.2 Finland: Vaccines Market Breakdown, by Route of Administration
11.3.1.10.3 Finland: Vaccines Market Breakdown, by Disease Indication
11.3.1.10.4 Finland: Vaccines Market Breakdown, by Age Group

11.3.1.11 Denmark: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.11.1 Denmark: Vaccines Market Breakdown, by Type
11.3.1.11.2 Denmark: Vaccines Market Breakdown, by Route of Administration
11.3.1.11.3 Denmark: Vaccines Market Breakdown, by Disease Indication
11.3.1.11.4 Denmark: Vaccines Market Breakdown, by Age Group

11.3.1.12 Sweden: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.12.1 Sweden: Vaccines Market Breakdown, by Type
11.3.1.12.2 Sweden: Vaccines Market Breakdown, by Route of Administration
11.3.1.12.3 Sweden: Vaccines Market Breakdown, by Disease Indication
11.3.1.12.4 Sweden: Vaccines Market Breakdown, by Age Group

11.3.1.13 Switzerland: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.13.1 Switzerland: Vaccines Market Breakdown, by Type
11.3.1.13.2 Switzerland: Vaccines Market Breakdown, by Route of Administration
11.3.1.13.3 Switzerland: Vaccines Market Breakdown, by Disease Indication
11.3.1.13.4 Switzerland: Vaccines Market Breakdown, by Age Group

11.3.1.14 Austria: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.14.1 Austria: Vaccines Market Breakdown, by Type
11.3.1.14.2 Austria: Vaccines Market Breakdown, by Route of Administration
11.3.1.14.3 Austria: Vaccines Market Breakdown, by Disease Indication
11.3.1.14.4 Austria: Vaccines Market Breakdown, by Age Group

11.3.1.15 Greece: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.15.1 Greece: Vaccines Market Breakdown, by Type
11.3.1.15.2 Greece: Vaccines Market Breakdown, by Route of Administration
11.3.1.15.3 Greece: Vaccines Market Breakdown, by Disease Indication
11.3.1.15.4 Greece: Vaccines Market Breakdown, by Age Group

11.3.1.16 Portugal: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.16.1 Portugal: Vaccines Market Breakdown, by Type
11.3.1.16.2 Portugal: Vaccines Market Breakdown, by Route of Administration
11.3.1.16.3 Portugal: Vaccines Market Breakdown, by Disease Indication
11.3.1.16.4 Portugal: Vaccines Market Breakdown, by Age Group

11.3.1.17 Russia: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.17.1 Russia: Vaccines Market Breakdown, by Type
11.3.1.17.2 Russia: Vaccines Market Breakdown, by Route of Administration
11.3.1.17.3 Russia: Vaccines Market Breakdown, by Disease Indication
11.3.1.17.4 Russia: Vaccines Market Breakdown, by Age Group

11.3.1.18 Poland: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.18.1 Poland: Vaccines Market Breakdown, by Type
11.3.1.18.2 Poland: Vaccines Market Breakdown, by Route of Administration
11.3.1.18.3 Poland: Vaccines Market Breakdown, by Disease Indication
11.3.1.18.4 Poland: Vaccines Market Breakdown, by Age Group

11.3.1.19 Romania: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.19.1 Romania: Vaccines Market Breakdown, by Type
11.3.1.19.2 Romania: Vaccines Market Breakdown, by Route of Administration
11.3.1.19.3 Romania: Vaccines Market Breakdown, by Disease Indication
11.3.1.19.4 Romania: Vaccines Market Breakdown, by Age Group

11.3.1.20 Czech Republic: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.20.1 Czech Republic: Vaccines Market Breakdown, by Type
11.3.1.20.2 Czech Republic: Vaccines Market Breakdown, by Route of Administration
11.3.1.20.3 Czech Republic: Vaccines Market Breakdown, by Disease Indication
11.3.1.20.4 Czech Republic: Vaccines Market Breakdown, by Age Group

11.3.1.21 Ukraine: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.21.1 Ukraine: Vaccines Market Breakdown, by Type
11.3.1.21.2 Ukraine: Vaccines Market Breakdown, by Route of Administration
11.3.1.21.3 Ukraine: Vaccines Market Breakdown, by Disease Indication
11.3.1.21.4 Ukraine: Vaccines Market Breakdown, by Age Group

11.3.1.22 Slovakia: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.22.1 Slovakia: Vaccines Market Breakdown, by Type
11.3.1.22.2 Slovakia: Vaccines Market Breakdown, by Route of Administration
11.3.1.22.3 Slovakia: Vaccines Market Breakdown, by Disease Indication
11.3.1.22.4 Slovakia: Vaccines Market Breakdown, by Age Group

11.3.1.23 Bulgaria: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.23.1 Bulgaria: Vaccines Market Breakdown, by Type
11.3.1.23.2 Bulgaria: Vaccines Market Breakdown, by Route of Administration
11.3.1.23.3 Bulgaria: Vaccines Market Breakdown, by Disease Indication
11.3.1.23.4 Bulgaria: Vaccines Market Breakdown, by Age Group

11.4 Asia-Pacific

11.4.1 Vaccines Market Breakdown, by Key Country, 2026 and 2033 (%)
11.4.1.1 Vaccines Market – Revenue and Forecast Analysis – by Country
11.4.1.1 China: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.1.1 China: Vaccines Market Breakdown, by Type
11.4.1.1.2 China: Vaccines Market Breakdown, by Route of Administration
11.4.1.1.3 China: Vaccines Market Breakdown, by Disease Indication
11.4.1.1.4 China: Vaccines Market Breakdown, by Age Group

11.4.1.2 Japan: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.2.1 Japan: Vaccines Market Breakdown, by Type
11.4.1.2.2 Japan: Vaccines Market Breakdown, by Route of Administration
11.4.1.2.3 Japan: Vaccines Market Breakdown, by Disease Indication
11.4.1.2.4 Japan: Vaccines Market Breakdown, by Age Group

11.4.1.3 South Korea: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.3.1 South Korea: Vaccines Market Breakdown, by Type
11.4.1.3.2 South Korea: Vaccines Market Breakdown, by Route of Administration
11.4.1.3.3 South Korea: Vaccines Market Breakdown, by Disease Indication
11.4.1.3.4 South Korea: Vaccines Market Breakdown, by Age Group

11.4.1.4 India: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.4.1 India: Vaccines Market Breakdown, by Type
11.4.1.4.2 India: Vaccines Market Breakdown, by Route of Administration
11.4.1.4.3 India: Vaccines Market Breakdown, by Disease Indication
11.4.1.4.4 India: Vaccines Market Breakdown, by Age Group

11.4.1.5 Australia: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.5.1 Australia: Vaccines Market Breakdown, by Type
11.4.1.5.2 Australia: Vaccines Market Breakdown, by Route of Administration
11.4.1.5.3 Australia: Vaccines Market Breakdown, by Disease Indication
11.4.1.5.4 Australia: Vaccines Market Breakdown, by Age Group

11.4.1.6 New Zealand: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.6.1 New Zealand: Vaccines Market Breakdown, by Type
11.4.1.6.2 New Zealand: Vaccines Market Breakdown, by Route of Administration
11.4.1.6.3 New Zealand: Vaccines Market Breakdown, by Disease Indication
11.4.1.6.4 New Zealand: Vaccines Market Breakdown, by Age Group

11.4.1.7 Indonesia: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.7.1 Indonesia: Vaccines Market Breakdown, by Type
11.4.1.7.2 Indonesia: Vaccines Market Breakdown, by Route of Administration
11.4.1.7.3 Indonesia: Vaccines Market Breakdown, by Disease Indication
11.4.1.7.4 Indonesia: Vaccines Market Breakdown, by Age Group

11.4.1.8 Malaysia: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.8.1 Malaysia: Vaccines Market Breakdown, by Type
11.4.1.8.2 Malaysia: Vaccines Market Breakdown, by Route of Administration
11.4.1.8.3 Malaysia: Vaccines Market Breakdown, by Disease Indication
11.4.1.8.4 Malaysia: Vaccines Market Breakdown, by Age Group

11.4.1.9 Philippines: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.9.1 Philippines: Vaccines Market Breakdown, by Type
11.4.1.9.2 Philippines: Vaccines Market Breakdown, by Route of Administration
11.4.1.9.3 Philippines: Vaccines Market Breakdown, by Disease Indication
11.4.1.9.4 Philippines: Vaccines Market Breakdown, by Age Group

11.4.1.10 Singapore: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.10.1 Singapore: Vaccines Market Breakdown, by Type
11.4.1.10.2 Singapore: Vaccines Market Breakdown, by Route of Administration
11.4.1.10.3 Singapore: Vaccines Market Breakdown, by Disease Indication
11.4.1.10.4 Singapore: Vaccines Market Breakdown, by Age Group

11.4.1.11 Thailand: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.11.1 Thailand: Vaccines Market Breakdown, by Type
11.4.1.11.2 Thailand: Vaccines Market Breakdown, by Route of Administration
11.4.1.11.3 Thailand: Vaccines Market Breakdown, by Disease Indication
11.4.1.11.4 Thailand: Vaccines Market Breakdown, by Age Group

11.4.1.12 Vietnam: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.12.1 Vietnam: Vaccines Market Breakdown, by Type
11.4.1.12.2 Vietnam: Vaccines Market Breakdown, by Route of Administration
11.4.1.12.3 Vietnam: Vaccines Market Breakdown, by Disease Indication
11.4.1.12.4 Vietnam: Vaccines Market Breakdown, by Age Group

11.4.1.13 Taiwan: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.13.1 Taiwan: Vaccines Market Breakdown, by Type
11.4.1.13.2 Taiwan: Vaccines Market Breakdown, by Route of Administration
11.4.1.13.3 Taiwan: Vaccines Market Breakdown, by Disease Indication
11.4.1.13.4 Taiwan: Vaccines Market Breakdown, by Age Group

11.4.1.14 Bangladesh: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.14.1 Bangladesh: Vaccines Market Breakdown, by Type
11.4.1.14.2 Bangladesh: Vaccines Market Breakdown, by Route of Administration
11.4.1.14.3 Bangladesh: Vaccines Market Breakdown, by Disease Indication
11.4.1.14.4 Bangladesh: Vaccines Market Breakdown, by Age Group

11.5 South and Central America

11.5.1 Vaccines Market Breakdown, by Key Country, 2026 and 2033 (%)
11.5.1.1 Vaccines Market – Revenue and Forecast Analysis – by Country
11.5.1.1 Brazil: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.1.1 Brazil: Vaccines Market Breakdown, by Type
11.5.1.1.2 Brazil: Vaccines Market Breakdown, by Route of Administration
11.5.1.1.3 Brazil: Vaccines Market Breakdown, by Disease Indication
11.5.1.1.4 Brazil: Vaccines Market Breakdown, by Age Group

11.5.1.2 Argentina: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.2.1 Argentina: Vaccines Market Breakdown, by Type
11.5.1.2.2 Argentina: Vaccines Market Breakdown, by Route of Administration
11.5.1.2.3 Argentina: Vaccines Market Breakdown, by Disease Indication
11.5.1.2.4 Argentina: Vaccines Market Breakdown, by Age Group

11.5.1.3 Chile: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.3.1 Chile: Vaccines Market Breakdown, by Type
11.5.1.3.2 Chile: Vaccines Market Breakdown, by Route of Administration
11.5.1.3.3 Chile: Vaccines Market Breakdown, by Disease Indication
11.5.1.3.4 Chile: Vaccines Market Breakdown, by Age Group

11.5.1.4 Colombia: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.4.1 Colombia: Vaccines Market Breakdown, by Type
11.5.1.4.2 Colombia: Vaccines Market Breakdown, by Route of Administration
11.5.1.4.3 Colombia: Vaccines Market Breakdown, by Disease Indication
11.5.1.4.4 Colombia: Vaccines Market Breakdown, by Age Group

11.5.1.5 Peru: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.5.1 Peru: Vaccines Market Breakdown, by Type
11.5.1.5.2 Peru: Vaccines Market Breakdown, by Route of Administration
11.5.1.5.3 Peru: Vaccines Market Breakdown, by Disease Indication
11.5.1.5.4 Peru: Vaccines Market Breakdown, by Age Group

11.6 Middle East and Africa

11.6.1 Vaccines Market Breakdown, by Key Country, 2026 and 2033 (%)
11.6.1.1 Vaccines Market – Revenue and Forecast Analysis – by Country
11.6.1.1 Saudi Arabia: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.1.1 Saudi Arabia: Vaccines Market Breakdown, by Type
11.6.1.1.2 Saudi Arabia: Vaccines Market Breakdown, by Route of Administration
11.6.1.1.3 Saudi Arabia: Vaccines Market Breakdown, by Disease Indication
11.6.1.1.4 Saudi Arabia: Vaccines Market Breakdown, by Age Group

11.6.1.2 United Arab Emirates: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.2.1 United Arab Emirates: Vaccines Market Breakdown, by Type
11.6.1.2.2 United Arab Emirates: Vaccines Market Breakdown, by Route of Administration
11.6.1.2.3 United Arab Emirates: Vaccines Market Breakdown, by Disease Indication
11.6.1.2.4 United Arab Emirates: Vaccines Market Breakdown, by Age Group

11.6.1.3 Kuwait: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.3.1 Kuwait: Vaccines Market Breakdown, by Type
11.6.1.3.2 Kuwait: Vaccines Market Breakdown, by Route of Administration
11.6.1.3.3 Kuwait: Vaccines Market Breakdown, by Disease Indication
11.6.1.3.4 Kuwait: Vaccines Market Breakdown, by Age Group

11.6.1.4 Bahrain: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.4.1 Bahrain: Vaccines Market Breakdown, by Type
11.6.1.4.2 Bahrain: Vaccines Market Breakdown, by Route of Administration
11.6.1.4.3 Bahrain: Vaccines Market Breakdown, by Disease Indication
11.6.1.4.4 Bahrain: Vaccines Market Breakdown, by Age Group

11.6.1.5 Qatar: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.5.1 Qatar: Vaccines Market Breakdown, by Type
11.6.1.5.2 Qatar: Vaccines Market Breakdown, by Route of Administration
11.6.1.5.3 Qatar: Vaccines Market Breakdown, by Disease Indication
11.6.1.5.4 Qatar: Vaccines Market Breakdown, by Age Group

11.6.1.6 Oman: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.6.1 Oman: Vaccines Market Breakdown, by Type
11.6.1.6.2 Oman: Vaccines Market Breakdown, by Route of Administration
11.6.1.6.3 Oman: Vaccines Market Breakdown, by Disease Indication
11.6.1.6.4 Oman: Vaccines Market Breakdown, by Age Group

11.6.1.7 Turkiye: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.7.1 Turkiye: Vaccines Market Breakdown, by Type
11.6.1.7.2 Turkiye: Vaccines Market Breakdown, by Route of Administration
11.6.1.7.3 Turkiye: Vaccines Market Breakdown, by Disease Indication
11.6.1.7.4 Turkiye: Vaccines Market Breakdown, by Age Group

11.6.1.8 South Africa: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.8.1 South Africa: Vaccines Market Breakdown, by Type
11.6.1.8.2 South Africa: Vaccines Market Breakdown, by Route of Administration
11.6.1.8.3 South Africa: Vaccines Market Breakdown, by Disease Indication
11.6.1.8.4 South Africa: Vaccines Market Breakdown, by Age Group

11.6.1.9 Egypt: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.9.1 Egypt: Vaccines Market Breakdown, by Type
11.6.1.9.2 Egypt: Vaccines Market Breakdown, by Route of Administration
11.6.1.9.3 Egypt: Vaccines Market Breakdown, by Disease Indication
11.6.1.9.4 Egypt: Vaccines Market Breakdown, by Age Group

11.6.1.10 Nigeria: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.10.1 Nigeria: Vaccines Market Breakdown, by Type
11.6.1.10.2 Nigeria: Vaccines Market Breakdown, by Route of Administration
11.6.1.10.3 Nigeria: Vaccines Market Breakdown, by Disease Indication
11.6.1.10.4 Nigeria: Vaccines Market Breakdown, by Age Group

11.6.1.11 Algeria: Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.11.1 Algeria: Vaccines Market Breakdown, by Type
11.6.1.11.2 Algeria: Vaccines Market Breakdown, by Route of Administration
11.6.1.11.3 Algeria: Vaccines Market Breakdown, by Disease Indication
11.6.1.11.4 Algeria: Vaccines Market Breakdown, by Age Group

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Bavarian Nordic A/S

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 GSK plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Emergent BioSolutions Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Merck & Co., Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Inovio Pharmaceuticals, Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Pfizer Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Sanofi

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 CSL Limited

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 AstraZeneca PLC

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Serum Institute of India Pvt. Ltd.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Access the Full Vaccines Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization